Clinical Trial

Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 2, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluation of the efficacy and safety of recombinant human thrombopoietin (rhTPO) at 300 U/kg/day for hematopoietic stem cell mobilization in autologous transplantation among acute leukemia patients
Trial Details
NCT Number NCT06955858
Lead Sponsor Institute of Hematology & Blood Diseases Hospital, China
Conditions Hematopoietic Stem Cell Mobilization
Enrollment 60 participants
Start Date 2025-05-30
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-02